FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, is Related to Disease ...
Introduction Crohn’s disease (CD) is a subtype of inflammatory bowel disease (IBD) that affects the gastrointestinal tract.1 The disease is characterized by periods of remission and relapse, with symptoms ranging from abdominal pain and diarrhea to severe …